WPI 3170 (Alendronate Sodium 10 mg)
Pill with imprint WPI 3170 is White, Elliptical / Oval and has been identified as Alendronate Sodium 10 mg. It is supplied by Watson Pharmaceuticals, Inc..
Alendronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3170
Alendronate Sodium
- Imprint
- WPI 3170
- Strength
- 10 mg
- Color
- White
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 00591-3170
More about alendronate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 106 Reviews
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.